At present, Zevra Therapeutics Inc. (ZVRA) has a stock price of $4.99. In the previous session, the stock saw a rise, peaking at $5.88 after an opening price of $5.83. The day’s lowest price was $4.87, and it closed at $5.84.
The market performance of Zevra Therapeutics Inc.’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $6.92 on 09/15/22, while the lowest value for the same duration was $4.03 on 06/16/22.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
52-week price history of ZVRA Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Zevra Therapeutics Inc.’s current trading price is -27.89% away from its 52-week high, while its distance from the 52-week low is 23.82%. The stock’s price range during the 52-week period has remained between $4.03 and $6.92. In the Healthcare sector, the company’s shares saw a trading volume of around 0.68 million for the day, which was evidently higher than the average daily volume of 0.26 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Zevra Therapeutics Inc. (ZVRA) has experienced a quarterly decline of -13.07% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 161.18M and boasts a workforce of 36 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.32, with a change in price of +0.40. Similarly, Zevra Therapeutics Inc. recorded 238,065 in trading volume during the last 100 days, posting a change of +8.71%.
Examining ZVRA’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ZVRA stands at 0.25. Similarly, the long-term debt-to-equity ratio is also 0.18.
ZVRA Stock Stochastic Average
Zevra Therapeutics Inc.’s raw stochastic average for the past 50 days is presently 34.68%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 44.25%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 73.56% and 78.91%, respectively.
ZVRA Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a gain of 8.71%.However, over the last six months, we can see a weaker performance of 4.18%. Over the last 30 days, the price of ZVRA has leaped by -3.67%. And in the last five days, it has fallen by -1.19%.